Table 1 Challenges associated with potency testing of cellular therapies
From: Potency analysis of cellular therapies: the emerging role of molecular assays
| ▪Limited quantity of final product to test |
| ▪Time to perform lot release testing is usually limited |
| ▪Stability of most cellular therapy products is limited |
| ▪Limited availability of reference standards |
| ▪Variability among lots is generally very high |